All In Biotech

Drug Trial Radar · NCT04029116

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) Compared to Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

Last checked: Nov 20, 2026Latest source record: Jun 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 440 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

440

Actual

Start

Oct 21, 2019

Primary completion

Sep 1, 2021

Study completion Nov 29, 2021

Sponsor

Lead sponsor
Scynexis, Inc.Industry
Sponsor type
Industry
First posted
Jul 23, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
Female only, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral ibrexafungerp (formerly "SCY-078") compared to placebo in female subjects 12 years and older with recurrent VVC (RVVC).

Conditions

  • Recurrent Vulvovaginal Candidiasis

Interventions

  • Fluconazole TabletDrug

    150 mg every 72 hours for 3 doses

  • IBREXAFUNGERPDrug

    300 mg BID (one day) every 4 weeks for a total of 6 dosing days

  • Placebo oral tabletDrug

    BID (one day) every 4 weeks for a total of 6 dosing days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical SuccessTime frame: Week 24

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Precision Trials LLC

    Phoenix, Arizona

  • Women's Healthcare Research Corp

    San Diego, California

  • Altus Research - Hunt - PPDS

    Lake Worth, Florida

  • New Age Medical Research Corporation

    Miami, Florida

  • Healthcare Clinical Data Inc

    North Miami, Florida

  • Clinical Research Prime - ClinEdge - PPDS

    Idaho Falls, Idaho

  • Clinical Trials Management

    Covington, Louisiana

  • Women Under Study, LLC

    New Orleans, Louisiana

  • Unified Women's Clinical Research

    Hagerstown, Maryland

  • Wayne State University

    Detroit, Michigan

  • Center For Women's Health and Wellness LLC

    Lawrenceville, New Jersey

  • Lawrence Obstetrics Gynecology Clinical Research LLC

    Lawrenceville, New Jersey

  • Bosque Women's Care

    Albuquerque, New Mexico

  • Carolina Women's Research and Wellness Center

    Durham, North Carolina

  • Unified Womens CLinical Research

    Greensboro, North Carolina

  • Unified Women's Clinical Research Raleigh

    Raleigh, North Carolina

  • M3 Wake Research, Inc

    Raleigh, North Carolina

  • Group For Women

    Winston-Salem, North Carolina

  • Lyndhurst Clinical Research

    Winston-Salem, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Obstetrics and Gynecology Associates of Erie, PC

    Erie, Pennsylvania

  • Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Chattanooga Medical Research Inc

    Chattanooga, Tennessee

  • Medical Research Center of Memphis, LLC

    Memphis, Tennessee

  • TMC Life Research Inc

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.